USD 37.5 Million Investment: Çerkezköy-2 Opens

World Medicine, Türkiye’s pharmaceutical export champion, continues its operations with a vision of delivering accessible and effective products worldwide. Having recently commissioned the Çerkezköy-2 facility, the foundations of which were laid several years ago, World Medicine is further accelerating its manufacturing momentum.

After commissioning the Çerkezköy-1 plant in 2021, one of the largest pharmaceutical manufacturing facilities in Türkiye and Eastern Europe, World Medicine subsequently put into service its additional manufacturing facility in 2022, representing an investment of approximately USD 37.5 million. The new World Medicine Çerkezköy-2 plant has a total indoor area of 23,000 m2 and includes a high-bay warehouse with a capacity of 24,000 pallets as well as an additional production area of 2,850 m2.

“Through our investments, we continue to grow every day in the pharmaceutical industry both in Türkiye and in the international arena,” said Sohrab Mammadli, Vice Chairman of the Board of Directors of World Medicine, emphasizing the company’s manufacturing strength following the launch of the new plant. Mammadli stated, “We act with the goal of exporting the medicines we manufacture in Türkiye to the world, and today we export to more than 50 countries across different continents. In order to meet demand in our existing and target markets, we continue to expand our manufacturing strength and maintain our investments without interruption. Our greatest goal is to become the pharmaceutical company that contributes the most to the Turkish economy as the one brand that first comes to mind when pharmaceutical exports are mentioned.”

Mammadli noted that the production facility is currently manufacturing pharmaceutical products in soft capsule form using advanced technology, operating with two production lines within the existing area and an annual capacity of 500 million capsules and approximately 50 million boxes. He also stated that the facility continues to grow internally through ongoing equipment investments for different product forms. He added that the next objective is to further increase World Medicine’s production volume through new investments both domestically and internationally.